Complementary and alternative medicine in tumor patients: A dilemma in modern oncology;Komplementäre und alternative medizin bei tumorpatienten: Ein dilemma in der modernen onkologie

Onkologe

Volumn 14, Issue 1, 2008, Pages 73-80

  Micke, O ^a   Buntzel J ^b  

^a FRANZISKUS HOSPITAL   (Germany)

^b Sudharz Krankenhaus Nordhausen   (Germany)

Author keywords

Alternative therapist; Complementary methods; Interactions; Oncologist; Side effects

Indexed keywords

ALTERNATIVE MEDICINE; CLINICAL PRACTICE; CLINICAL STUDY; CULTURAL FACTOR; FINANCIAL MANAGEMENT; HEALTH CARE PERSONNEL; HUMAN; NEOPLASM; PHYSICIAN; REVIEW;

EID: 39149143667     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-007-1295-8     Document Type: Review

References (65)

1. Arras HE, Bierter W (1989) Welche Zukunft haben wir? Christoph-Merian, Basel
2. Asher BF, Seidman M, Snyderman C (2001) Complementary and alternative medicine in otolaryngology. Laryngoscope 111: 1383-1389
3. Astin JA(1998) Why patients use alternative medicine: results of a national study. JAMA 279: 1548-1553
4. Astin JA, Reilly C, Perkins C, Child WL (2006) Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. J Soc Integr Oncol 4: 157-169
5. Beuth J (2007) Evidenzbasierte Komplementäronkologie. Onkologe 13: 534-542
6. Boon H, Stewart M, Kennard MA et al. (2000) Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18: 2515-2521
7. Bruns F, Steinmann D, Micke O (2007) Spiritualität in der Onkologie. Onkologe 13: 490-498
8. Bruns F, Glatzel M, Schönekaes K et al. (2006) Complementary and alternative medicine experience in radiation oncology patients: first results of a multi-center approach. Trace Elem Electrolytes 23: 318-326
9. Büntzel J, Sayer B, Büntzel H, Müller C (2007) Unkonventionelle Behandlungsansätze in der Palliativmedizin. Onkologe 13: 509-519
10. Büntzel J, Mücke R, Schäfer U, Micke O (2006) Use of complementary and alternative medicine (CAM) in head and neck cancer - is it really limited? Laryngoscope 116: 506-507
11. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340: 1733-1739
12. Burstein HJ (2000) Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol 18: 2501-2504
13. Cheng B, Hung CT, Chiu W (2002) Herbal medicine and anaesthesia. Hong Kong Med J 8: 123-130
14. Corbin L (2005) Safety and efficacy of massage therapy for patients with cancer. Cancer Control 12: 158-164
15. Drew AK, Bensoussan A, Whyte IM et al. (2002) Chinese herbal medicine toxicology database: monograph on Radix Sophorae Flavescentis,.,ku shen". J Toxicol 40: 173-176
16. Drew AK, Whyte IM, Bensoussan A et al. (2002a) Chinese herbal medicine toxicology database: monograph on Herba Asari,.,xi xin". J Toxicol 40: 169-172
17. Dudenredaktion (Hrsg) (2006) Duden 07. Das Herkunftswörterbuch. 4. überarb. Aufl. Bibliographisches Institut, Mannheim
18. Eisenberg DM, Davis RB, Ettner SL et al. (1998) Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280: 1569-1575
19. Eisenberg DM, Kessler RC, Foster C et al. (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328: 246-252
20. Ernst E (2000) 'Alternative cancer cures': looking for common ground. Lancet Oncol 1: 54-55
21. Ernst E (2001) Alternative cancer cures. Br J Cancer 85: 781-782
22. Ernst E (2001a) Intangible risks of complementary and alternative medicine. J Clin Oncol 19: 2365-2366
23. Ernst E (2002).,Alternative" medicine and science - like fire and water? Wien Klin Wochenschr 114: 655-656
24. Fernandez CV, Stutzer CA, MacWilliam L, Fryer C (1998) Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol 16: 1279-1286
25. Fugh-Berman A (2000) Herb-drug interactions. Lancet 355: 134-138
26. Gertz MA, Bauer BA (2001) Caring (really) for patients who use alternative therapies for cancer. J Clin Oncol 19: 4346-4349
27. Greenhalgh T, Hurwitz B (2005) Narrative-based Medicine - Sprechende Medizin. Hans Huber, Bern
28. Grothey A, Duppe J, Hasenburg A, Voigtmann R (1998) [Use of alternative medicine in oncology patients]. Dtsch Med Wochenschr 123: 923-929
29. Izzo AA, Ernst E (2001) Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61: 2163-2175
30. Lampe H, Jun X, Micke O, Bodenstein H (2007) Traditionelle Chinesische Medizin in der Onkologie. Onkologe 13: 499-508
31. Lewith GT (2000) Complementary and alternative medicine: an educational, attitudinal and research challenge. Med J Aust 172: 102-103
32. Lissoni P, Barni S, Ardizzoa A (1994) A randomized study with pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. Cancer 73: 699-701
33. Markman M (2001) Interactions between academic oncology and alternative/complementary/integrative medicine: complex but necessary. J Clin Oncol 19: 52S-53S
34. Markman M (2002) Safety issues in using complementary and alternative medicine. J Clin Oncol 20: 39S-41S
35. Marquard O (1981) Ende des Schicksals? Einige Bemerkungen über die Unvermeidlichkeit des Unverfügbaren. In: ders., Abschied vom Prinzipiellen. Philosophische Studien. Reclams Universal-Bibliothek, Stuttgart, S 67-90
36. McGinnis LS (1991) Alternative therapies, 1990. An overview. Cancer 67: 1788-1792
37. Metz JM (2000).,Alternative medicine" and the cancer patient: an overview. Med Pediatr Oncol 34: 20-26
38. Micke O, Mucke R, Schonekaes K, Buntzel J (2003) Complementary and alternative medicine in radiotherapy patients-more harm than expected? In regard to D'Amico et al.: self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. IJROBP 2002; 54: 1311-1313. Int J Radiat Oncol Biol Phys 57: 1197-1198
39. Micke O, Haverkamp U (2004) High Tech versus sanfte Medizin - (K)ein Widerspruch. 5. Wiesbadener Strahlentherapiesymposium: High Tech versus sanfte Medizin. Wiesbaden 2004
40. Micke O, Büntzel J, Glatzel M et al. (2007) Komplementäre und alternative Therapieverfahren bei Tumorpatienten: Vitamine für.,ein besseres Gefühl" Im Focus Onkologie 1-2: 65-69
41. Micke O, Büntzel J, Höffken K (2007a) Was wollen Tumorpatienten? Onkologe 13: 475-476
42. Münstedt K (2005) Ratgeber unkonventionelle Krebstherapien. 2. Aufl. Ecomed, Landsberg
43. Münstedt K, Brüggmann D, Jungi WF (2007) Naturheilkunde und Komplementärmedizin in der Tumortherapie. Gefahren, Aufklärungsbedarf und Qualitätssicherung. Onkologe 13: 528-533
44. Paltiel O, Avitzour M, Peretz T et al. (2001) Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 19: 2439-2448
45. Patterson RE, Neuhouser ML, Hedderson MM et al. (2002) Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8: 477-485
46. Richardson MA, Sanders T, Palmer JL et al. (2000) Complementary/ alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18: 2505-2514
47. Risberg T, Lund E, Wist E (1995) Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol 34: 893-898
48. Rosenthal DS, Dean-Clower E (2005) Integrative medicine in hematology/oncology: benefits, ethical considerations, and controversies. Hematology (Am Soc Hematol Educ Program) 491-497
49. Ryan M, Ratcliffe J, Tucker J (1997) Using willingness to pay to value alternative models of antenatal care. Soc Sci Med 44: 371-380
50. Schönekaes K, Micke O, Mücke R et al. (2003) [Use of complementary/alternative therapy methods by patients with breast cancer]. Forsch Komplementarmed Klass Naturheilkd 10: 304-308
51. Shen J, Andersen R, Albert PS et al. (2002) Use of complementary/ alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med 2: 8
52. Shumay DM, Maskarinec G, Gotay CC et al. (2002) Determinants of the degree of complementary and alternative medicine use among patients with cancer. J Altern Complement Med 8: 661-671
53. SKAK (Schweizerische Studiengruppe für Komplementäre und Alternative Methoden bei Krebs) (2006) Ukrain. Dokumentation Nr. 06/08. Krebsliga Schweiz, Bern
54. Slifman NR, Obermeyer WR, Aloi BK et al. (1998) Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 339: 806-811
55. Snodgrass SR (19992) Vitamin neurotoxicity. Mol Neurobiol 6: 41-73
56. Söllner W, Zingg-Schir M, Rumpold G, Fritsch P (1997) Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol 133: 316-321
57. Söllner W, Maislinger S, DeVries A et al. (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89: 873-880
58. Söllner W, Maislinger S, Kappauf H (2003) How to improve communication between physicians and cancer patients about use of complementary and alternative medicine? Psychooncology 12: 203-204
59. Sparber A, Bauer L, Curt G et al. (2000) Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum 27: 623-630
60. Spengler O (1931) Der Mensch und die Technik. Beitrag zu einer Philosophie des Lebens. Beck, München
61. Stern S (2007) Die Kämpferin: Porträt Karin Kraft. Kma 7: 64-67
62. Tibballs G (1997) Titanic. Der Mythos des "unsinkbaren" Luxusliners. Gondrom, Bindlach
63. Tucker GM (2002) Policy on alternative therapies. Am J Health Syst Pharm 59: 198
64. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4: 274-286
65. White AR, Ernst E (2000) Economic analysis of complementary medicine: a systematic review. Complement Ther Med 8: 111-118